Literature DB >> 17126518

Isolation and characterization of degradation impurities in docetaxel drug substance and its formulation.

Dinesh Kumar1, Rajesh Singh Tomar, Santosh Kumar Deolia, Moloy Mitra, Rama Mukherjee, Anand C Burman.   

Abstract

The degradation of docetaxel drug substance and its injection formulation has been investigated. The majority of impurities were observed in a base degradation study and all five degradation products were characterized. These impurities were isolated, enriched and were subjected to mass and NMR spectral studies. Based on the spectral data, these were characterized as 10-deacetyl baccatin III, 7-epi-10-deacetyl baccatin III, 7-epi-10-oxo-10-deacetyl baccatin III, 7-epi docetaxel and 7-epi-10-oxo-docetaxel, respectively. The last two impurities were also detected in the stability study of docetaxel formulation. Out of these degradation impurities two substances have been previously identified while the other three previously unreported.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126518     DOI: 10.1016/j.jpba.2006.10.015

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Is an alternative drug delivery system needed for docetaxel? The role of controlling epimerization in formulations and beyond.

Authors:  Arehalli S Manjappa; Peeyush N Goel; Makam P Vekataraju; Kesarla S Rajesh; Kinjal Makwana; Mukesh Ukawala; Yuvraj Nikam; Rajiv P Gude; Rayasa S Ramachandra Murthy
Journal:  Pharm Res       Date:  2013-06-12       Impact factor: 4.200

2.  Evaluation of the pharmaceutical quality of docetaxel injection using new stability indicating chromatographic methods for assay and impurities.

Authors:  Annarapu Malleswara Reddy; Nagaraju Banda; Shinde Govind Dagdu; Dama Venugopala Rao; Chandra Sekhar Kocherlakota; Vyas Krishnamurthy
Journal:  Sci Pharm       Date:  2010-03-05

3.  Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene-docetaxel conjugate.

Authors:  Yong Joo Jun; Jung Hyun Park; Prakash G Avaji; Kyung Su Park; Kyung Eun Lee; Hwa Jeong Lee; Youn Soo Sohn
Journal:  Int J Nanomedicine       Date:  2017-07-27

4.  Influence of Polymer Composition on the Controlled Release of Docetaxel: A Comparison of Non-Degradable Polymer Films for Oesophageal Drug-Eluting Stents.

Authors:  Paris Fouladian; Franklin Afinjuomo; Mohammad Arafat; Amanda Bergamin; Yunmei Song; Anton Blencowe; Sanjay Garg
Journal:  Pharmaceutics       Date:  2020-05-11       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.